Matthew Reisteter serves as the Vice President of Sales at MANGO INC, where he is at the forefront of driving innovative solutions in the Life Science and Biopharma sectors. With over a decade of capital sales experience and a robust eight years specifically in the...
Matthew Reisteter serves as the Vice President of Sales at MANGO INC, where he is at the forefront of driving innovative solutions in the Life Science and Biopharma sectors. With over a decade of capital sales experience and a robust eight years specifically in the microbiology industry, Matthew is uniquely positioned to lead MANGO INC's ambitious initiatives. His current focus is on the development and commercialization of a Rapid Microbial Method for USP 61 and 62, aimed at enhancing quality control laboratories within the Pharmaceutical, Biopharmaceutical, and CGTx markets. This cutting-edge solution is designed to streamline in-process bioburden testing, ensuring that clients can maintain compliance with rigorous industry standards while optimizing their operational efficiencies.
Matthew's expertise in national sales management and solution selling allows him to effectively engage with leaders and C-suite executives, fostering relationships that drive technological advancements and business growth. His strategic planning skills are complemented by a deep understanding of the manufacturing processes and regulatory landscapes that govern the pharmaceutical industry. By leveraging his extensive background in revenue assurance and lead development, Matthew is committed to not only meeting but exceeding sales targets, ultimately contributing to MANGO INC's mission of delivering transformative solutions that enhance the quality and safety of life sciences products.
In an ever-evolving industry, Matthew strives to remain at the cutting edge of science and engineering, continuously seeking opportunities to innovate and adapt. His passion for engaging with key stakeholders and his dedication to advancing the capabilities of QC laboratories position him as a thought leader and a driving force within MANGO INC and the broader biopharma landscape.
